We are live on ! Find out more
SCP

Sandhill Capital Partners Portfolio holdings

AUM $1.16B
1-Year Est. Return 12.37%
This Fund
S&P 500
This Quarter Est. Return
+7.1%
1 Year Est. Return
+12.37%
3 Year Est. Return
+56.48%
5 Year Est. Return
+73.2%
10 Year Est. Return
+460.75%
AUM
$1.18B
AUM Growth
+$85.1M
Cap. Flow
+$45.3M
Cap. Flow %
3.85%
Top 10 Hldgs %
39.51%
Holding
94
New
10
Increased
51
Reduced
16
Closed
8

Top Buys

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$40.5M
2
NFLX icon
Netflix
NFLX
+$39.7M
3
PYPL icon
PayPal
PYPL
+$34M
4
SLG icon
SL Green Realty
SLG
+$33.4M
5
SPGI icon
S&P Global
SPGI
+$16.8M

Sector Composition

Rank Sector Weight
1 Technology 23.26%
2 Healthcare 19.24%
3 Industrials 15.14%
4 Financials 12.09%
5 Materials 9.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AWI icon
76
Armstrong World Industries
AWI
$7.84B
$253K 0.02%
2,811
-73
-3% -$6.2K
MTNB icon
77
Matinas BioPharma
MTNB
$1.81M
$21K ﹤0.01%
400
+200
+100% +$13.4K
NMTR
78
DELISTED
9 Meters Biopharma
NMTR
$12K ﹤0.01%
500
BEEM icon
79
Beam Global
BEEM
$25.3M
-3,333
Closed -$246K
EEFT icon
80
Euronet Worldwide
EEFT
$2.7B
-124,515
Closed -$18M
GWRE icon
81
Guidewire Software
GWRE
$14.2B
-160,187
Closed -$20.6M
NDSN icon
82
Nordson
NDSN
$17.3B
-64,713
Closed -$13M
SSNC icon
83
SS&C Technologies
SSNC
$18.6B
-360,740
Closed -$26.2M

Similar funds

Sandhill Capital Partners's Q1 2021 Portfolio in Review

As of Q1 2021, Sandhill Capital Partners held 94 positions worth $1.18B, up 7.8% from $1.09B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Sandhill Capital Partners deployed $45.3M of net new capital in Q1 2021, opening 10 new positions and adding to 51 existing holdings. Its largest new stake was Vertex Pharmaceuticals: 184,175 shares worth $39.6M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 33% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was JPMorgan Chase, an estimated $24.2M trimmed.

  • Sandhill Capital Partners's largest Q1 2021 buy was Vertex Pharmaceuticals: 184,175 shares worth $39.6M.
  • Sandhill Capital Partners added most to S&P Global in Q1 2021, an estimated $16.8M increase.
  • Sandhill Capital Partners's biggest Q1 2021 reduction was JPMorgan Chase, cutting an estimated $24.2M.
  • Sandhill Capital Partners fully exited SS&C Technologies in Q1 2021, selling an estimated $26.2M.
  • Sandhill Capital Partners's ten largest holdings make up 40% of its $1.18B portfolio in Q1 2021.
  • Sandhill Capital Partners opened 10 new positions and closed 8 in Q1 2021.
  • Sandhill Capital Partners's portfolio value rose 7.8% quarter-over-quarter to $1.18B.

Based on Sandhill Capital Partners's 13F filing for Q1 2021, filed 13 May 2021.